• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Icongene therapy

gene therapy

As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic data of tens of millions of consented volunteers, health data startup Truveta announced Jan. 13, 2025.
HealthPharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025
Rylae-Ann Poulin
Health‘There’s a lot of exciting times ahead of us’: Game-changing gene therapy for brain disorders is right around the corner
By Laura Ungar and The Associated PressJanuary 24, 2023
Novartis Zolgensma Gene Therapy Sales
NewslettersWhy a drug that costs $2.1 million per dose is on a sales streak
By Sy MukherjeeJanuary 29, 2020
Landlord To The Biotechs
HealthBiogen Acquires Nightstar Therapeutics in $800 Million Gene Therapy Deal
By Don ReisingerMarch 4, 2019
Pipette adding sample to petri dish with DNA profiles in background
HealthRoche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist Spark
By Tim Loh, Naomi Kresge and BloombergFebruary 25, 2019
LeadershipNovartis CEO Has One New Breakthrough Drug in the Medicine Cabinet: But It Could Be Costly
By Susie GharibNovember 30, 2018
HealthWhy Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You’ve Never Heard Of
By Hallie DetrickApril 9, 2018
HealthAntisense and Sensibility: Why RNA Is the New DNA
By Clifton LeafJanuary 4, 2018
Iris Network Student
HealthThe First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By Sy MukherjeeDecember 19, 2017
Iris Network Student
HealthGene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By Sy MukherjeeNovember 16, 2017
HealthIs $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
CommentaryInnovative Drugs Deserve Innovative Pricing
By David Agus, Dana Goldman and Bethany CiancioloAugust 31, 2017
Sickle Cell Anemia SEM
HealthBluebird Bio’s New Treatment Cured Sickle Cell in a Teenage Boy
By Sy MukherjeeMarch 3, 2017
DNA genetic testing (crop)
HealthGlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By Sy MukherjeeApril 4, 2016
1
  • 1
1
Most Popular
C-Suite
OpenAI’s Sam Altman says his highly disciplined daily routine has ‘fallen to crap’—and now unwinds on weekends at a ranch with no cell phone serviceAn image of a popular article
By Jacqueline MunisFebruary 5, 2026
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with TrumpAn image of a popular article
By Tristan BoveFebruary 3, 2026
Travel & Leisure
How Japan replaced France as the country young Americans obsessively romanticize—they’re longing for civility they don’t see at homeAn image of a popular article
By Nick LichtenbergFebruary 5, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.